4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001159036-26-000133
Director sold 5,230 shares at an average $108.54 ($567,661)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Posard Matthew L. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-01 | Sale : show line 1 in the form 10b5-1 | −730 | $107.17 | $78,233 | 58,109 | D |
| 2026-10-01 | Sale : show line 2 in the form 10b5-1 | −3,300 | $108.45 | $357,898 | 54,809 | D |
| 2026-10-01 | Sale : show line 3 in the form 10b5-1 | −1,100 | $109.57 | $120,526 | 53,709 | D |
| 2026-10-01 | Sale : show line 4 in the form 10b5-1 | −100 | $110.04 | $11,004 | 53,609 | D |
| Open-market sales · 5,230 sh · avg $108.54 · $567,661 | ||||||
Loading xslF345X06/wk-form4_1790973495.xml…